Medical products maker Smith+Nephew soars as turnaround plan boosts profit
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 05 2025
0mins
Source: Reuters
Financial Performance and Share Buyback: Smith+Nephew exceeded first-half profit expectations with a trading profit of $523 million, prompting a $500 million share buyback program that boosted shares by over 15%.
Operational Improvements and Market Strategy: The company reported strong revenue growth across all business sectors, attributed to cost-cutting measures and product launches, while maintaining its 2025 outlook despite challenges from U.S. tariffs and the Chinese market.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
